Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marylyn M Addo

Showing results (1-10 of 183) with videos related to

Pageof 19
Sort By:
Deutsche Medizinische Wochenschrift (1946)|October 4, 2023
[Think TB: keeping Tuberculosis in mind, diagnosing it and treating it correctly]Marylyn M Addo
Deutsche Medizinische Wochenschrift (1946)|June 7, 2022
[Travel medicine picks up speed again!]Marylyn M Addo
The Journal of Infectious Diseases|June 27, 2014
Sex-based differences in HIV type 1 pathogenesisMarylyn M Addo, Marcus Altfeld
Frontiers in Immunology|January 25, 2021
Sex Differences in Immunity: Implications for the Development of Novel Vaccines Against Emerging PathogensAnahita Fathi, Marylyn M Addo, Christine Dahlke
The New England Journal of Medicine|April 2, 2015
Severe Ebola virus infection complicated by gram-negative septicemiaBenno Kreuels, Marylyn M Addo, Stefan Schmiedel
Human Vaccines & Immunotherapeutics|August 2, 2019
Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogensAnahita Fathi, Christine Dahlke, Marylyn M Addo
Advances in Experimental Medicine and Biology|May 11, 2021
The COVID-19 Vaccine LandscapeTill Koch, Anahita Fathi, Marylyn M Addo
Deutsches Arzteblatt International|November 28, 2018
Tuberculous TenosynovitisThomas Theo Brehm, Stefan Schmiedel, Marylyn M Addo
Signal Transduction and Targeted Therapy|December 13, 2024
Correction: Next-generation mpox vaccines: efficacy of mRNA-1769 compared to modified vaccinia virus Ankara in non-human primatesLeonie Mayer, Leonie M Weskamm, Marylyn M Addo
Signal Transduction and Targeted Therapy|November 20, 2024
Next-generation mpox vaccines: efficacy of mRNA-1769 compared to modified vaccinia virus Ankara in non-human primatesLeonie Mayer, Leonie M Weskamm, Marylyn M Addo
Pageof 19

Showing results (1-10 of 183) with videos related to

Sort By:
Pageof 19
Deutsche Medizinische Wochenschrift (1946)|October 4, 2023
[Think TB: keeping Tuberculosis in mind, diagnosing it and treating it correctly]Marylyn M Addo
Deutsche Medizinische Wochenschrift (1946)|June 7, 2022
[Travel medicine picks up speed again!]Marylyn M Addo
The Journal of Infectious Diseases|June 27, 2014
Sex-based differences in HIV type 1 pathogenesisMarylyn M Addo, Marcus Altfeld
Frontiers in Immunology|January 25, 2021
Sex Differences in Immunity: Implications for the Development of Novel Vaccines Against Emerging PathogensAnahita Fathi, Marylyn M Addo, Christine Dahlke
The New England Journal of Medicine|April 2, 2015
Severe Ebola virus infection complicated by gram-negative septicemiaBenno Kreuels, Marylyn M Addo, Stefan Schmiedel
Human Vaccines & Immunotherapeutics|August 2, 2019
Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogensAnahita Fathi, Christine Dahlke, Marylyn M Addo
Advances in Experimental Medicine and Biology|May 11, 2021
The COVID-19 Vaccine LandscapeTill Koch, Anahita Fathi, Marylyn M Addo
Deutsches Arzteblatt International|November 28, 2018
Tuberculous TenosynovitisThomas Theo Brehm, Stefan Schmiedel, Marylyn M Addo
Signal Transduction and Targeted Therapy|December 13, 2024
Correction: Next-generation mpox vaccines: efficacy of mRNA-1769 compared to modified vaccinia virus Ankara in non-human primatesLeonie Mayer, Leonie M Weskamm, Marylyn M Addo
Signal Transduction and Targeted Therapy|November 20, 2024
Next-generation mpox vaccines: efficacy of mRNA-1769 compared to modified vaccinia virus Ankara in non-human primatesLeonie Mayer, Leonie M Weskamm, Marylyn M Addo
Pageof 19